Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
15 Jun 2015
1 in 5 Young VTE Patients Require Psychotropic Drugs within 5 Years
Dubrovnik, Croatia – 14 June 2015: One in five young people who experience a venous thromboembolism (VTE)1 will require psychotropic medication…
8 Jun 2015
Asthma Treatment Breakthrough Brings Hope to Millions
ASTHMA sufferers worldwide could soon benefit from the results of a ground-breaking study conducted by Cardiff University, Cardiff, UK, which has…
8 Jun 2015
3D-Printed Implants Save Lives of Babies with Tracheobronchomalacia
THREE babies suffering from an airway condition that presented little chance of them reaching young childhood have had their lives saved by…
2
Mins
4 Jun 2015
The Last Frontier, Men’s Health
The 21st century is well upon us, and the scientific and health landscape is rapidly changing, yet there are still new horizons to conquer.
4 Jun 2015
Dr Kevin Campbell, Our #EMJExpert, Answers Your Questions for Heart Rhythm Week
In support of Heart Rhythm Week, an annual campaign designed to raise global awareness and understanding of arrhythmias, we invited world-renowned…
2 Jun 2015
Early-Stage Trial of Nivolumab in Advanced Liver Cancer
Findings from a phase I/II study suggest that nivolumab is safe and effective in advanced liver cancer. Based on the results of the phase I part of the…
2 Jun 2015
Genomic Marker Predicts Anti-PD-1 Response in Several Cancers
A phase II study identified the first genomic marker – mismatch repair (MMR) deficiency – to predict response to the anti-PD-1 antibody pembrolizumab…
2 Jun 2015
Pembrolizumab Shows Promising Activity Against Head and Neck Cancer
A 132-patient study indicates that pembrolizumab immunotherapy is effective for patients with recurrent or metastatic head and neck cancer (HNC). The…
2 Jun 2015
Nivolumab Extends Survival for Patients With the Most Common Lung Cancer
Findings from a randomised phase III study indicate that PD-1 immunotherapy is an effective treatment option for patients with non-squamous, non-small…
2 Jun 2015
An introduction to ASCO 2015 by the 2014-15 president, Peter Paul Yu, MD, FACP, FASCO
Peter Paul Yu, MD, FACP, FASCO introduces ASCO 2015 and the conference themes – how to utilise data, to transform it into learning to impact patient care.
←
1
2
3
…
920
921
922
923
924
925
926
…
979
980
981
→